{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:51:44Z","timestamp":1776909104210,"version":"3.51.2"},"reference-count":36,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1538,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1742-1241.2011.02695.x","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T13:05:27Z","timestamp":1308315927000},"page":"903-910","source":"Crossref","is-referenced-by-count":24,"title":["Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS)"],"prefix":"10.1155","volume":"65","author":[{"given":"M.-\u00c1.","family":"Barba-Romero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rivera-Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pintos-Morell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Spanish FOS-Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,16]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB1|cit1","first-page":"3733","volume-title":"The Metabolic and Molecular Basis of Inherited Diseases","author":"Desnick","year":"2001"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS-the Fabry Outcome Survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J Med Genet"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB3|cit3","first-page":"30","article-title":"The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease","volume":"102","author":"Konreich","year":"1989","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB4|cit4","unstructured":"Cooper DN Ball EV Stenson PD , Philips AD Shaw K Mort ME The Human Genetic Mutation Database at the Institute of Medical Genetics [Internet]. Cardiff (UK). [cited 2011 March 28] http:\/\/www.hgmd.cf.ac.uk\/ac\/gene.php?gene=GLA"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural History of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet Med"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.gim.0000223545.63012.5a","article-title":"Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population and patients with other chronic disease","volume":"8","author":"Street","year":"2006","journal-title":"Genet Med"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/190372a0","article-title":"Gene action in the X-chromosome of the mouse (Mus musculus L.)","volume":"190","author":"Lyon","year":"1961","journal-title":"Nature"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.a.30123","article-title":"Inheritance of most X-linked traits is not dominant or recessive, just X-linked","volume":"129","author":"Dobyns","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Gen"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A-replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1756 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl. 2","key":"10.1111\/j.1742-1241.2011.02695.x-BIB19|cit19","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"Nacional Kidney Foundation (NKF) Kidney disease Outcome Quality Initiative (K\/DOQI) Advisory Board","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","article-title":"Validation of the Brief Pain Inventory for chronic nonmalignant pain","volume":"5","author":"Tang","year":"2004","journal-title":"J Pain"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol - a new facility for the measurement of health-related quality of life","volume":"16","author":"The EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin Genet"},{"issue":"Suppl. 3","key":"10.1111\/j.1742-1241.2011.02695.x-BIB24|cit24","first-page":"1","article-title":"La enfermedad de Fabry como modelo de enfermedad multisist\u00e9mica [Fabry disease as a model of multi-system disease, article in Spanish]","volume":"206","author":"Barbado Hern\u00e1ndez","year":"2006","journal-title":"Rev Clin Esp"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0140-6736(09)61493-8","article-title":"Enzyme replacement therapy with agalsidase alfa in patients with Fabry\u2019s disease: an analysis of registry data","volume":"374","author":"Mehta","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijcard.2008.04.075","article-title":"Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy","volume":"132","author":"Toro","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/11.supp7.4","article-title":"Rare diseases in renal replacement therapy in the ERA-EDTA Registry","volume":"11","author":"Tsakiris","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1523-1755.2002.00097.x","article-title":"Patients with Fabry disease on dialysis in the United States","volume":"61","author":"Thadani","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/TP.0b013e318191a842","article-title":"Kidney transplant outcomes in patients with Fabry disease","volume":"87","author":"Shah","year":"2009","journal-title":"Transplantantion"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events. Natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004728-200403000-00002","article-title":"Fabry disease: renal sonographic and magnetic resonance imaging findings in affected males and carrier females with the classic and cardiac variant phenotype","volume":"28","author":"Glass","year":"2004","journal-title":"J Comput Assist Tomogr"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1523-1755.2004.00846.x","article-title":"Parapelvic kidney cysts: a distinguishing feature with high prevalence in Fabry disease","volume":"66","author":"Ries","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jmg.2004.025791","article-title":"Effects on enzyme replacement therapy on pain and health-related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey)","volume":"42","author":"Hoffmann","year":"2005","journal-title":"J Med Genet"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1300\/J013v12n02_07","article-title":"Sex differentials in health and mortality","volume":"12","author":"Verbrugge","year":"1982","journal-title":"Wom Health"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000168482","article-title":"International Fabry Outcome Survey Investigators. Agalsidase alfa slows the decline in renal function in patients with Fabry disease","volume":"29","author":"Feriozzi","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1742-1241.2011.02695.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1399-0004.2009.01345.x","article-title":"Does geographical location influence de phenotype of Fabry disease in women in Europe?","volume":"77","author":"Barba-Romero","year":"2010","journal-title":"Clin Genet"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02695.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2011.02695.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:07:55Z","timestamp":1643332075000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2011.02695.x"}},"subtitle":["Fabry disease, in Spain and compared to Europe"],"short-title":[],"issued":{"date-parts":[[2011,6,16]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02695.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,16]]}}}